financetom
Business
financetom
/
Business
/
Mithaq Files Proxy Circular Ahead of Aimia's Annual Meeting
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mithaq Files Proxy Circular Ahead of Aimia's Annual Meeting
Jun 5, 2024 11:41 AM

02:18 PM EDT, 06/05/2024 (MT Newswires) -- Mithaq Capital SPC, the largest shareholder of Aimia ( AIMFF ) , on Wednesday said it filed a dissident proxy circular in connection with the upcoming annual meeting of Aimia ( AIMFF ) shareholders on June 26.

Mithaq said it is continuing its proxy battle "because of its ongoing concerns with the strategic direction and corporate governance practice of Aimia's ( AIMFF ) leadership".

Mithaq controls 26.8 million Aimia ( AIMFF ) shares, a 26.98% stake in the investment holding company.

Mithaq is looking for shareholders to back its six nominees for Aimia's ( AIMFF ) board.

Price: 2.98, Change: -0.02, Percent Change: -0.67

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioNTech's cancer drug meets primary endpoint in Phase 2 trial
BioNTech's cancer drug meets primary endpoint in Phase 2 trial
Jul 30, 2024
(Reuters) - COVID-19 vaccine maker BioNTech's cancer drug candidate BNT111 showed significant improvement in the response rate in patients with advanced melanoma during a Phase 2 trial, the German company said on Tuesday. The trial met its primary endpoint, with data demonstrating a statistically significant improvement in the overall response rate in patients treated with the mRNA immunotherapy candidate BNT111...
Leidos Holdings' Q2 Non-GAAP Earnings, Revenue Increase
Leidos Holdings' Q2 Non-GAAP Earnings, Revenue Increase
Jul 30, 2024
06:52 AM EDT, 07/30/2024 (MT Newswires) -- Leidos Holdings ( LDOS ) reported Q2 non-GAAP earnings Tuesday of $2.63 per diluted share, up from $1.80 per share a year earlier. Analysts surveyed by Capital IQ expected $2.27. Revenue for the quarter ended June 28 was $4.13 billion, up from $3.84 billion a year earlier. Analysts polled by Capital IQ expected...
Pfizer raises annual profit forecast after better-than-expected COVID sales
Pfizer raises annual profit forecast after better-than-expected COVID sales
Jul 30, 2024
(Reuters) - U.S. drugmaker Pfizer ( PFE ) raised its annual profit forecast on Tuesday after posting better-than-expected sales for its COVID vaccine and antiviral treatment. New Jersey-based Pfizer ( PFE ) now expects annual profit to be in the range of $2.45 to $2.65 per share, compared with its prior profit forecast of $2.15 to $2.35 per share. With...
Fresenius Medical Care Q2 Earnings Rise, Revenue Falls
Fresenius Medical Care Q2 Earnings Rise, Revenue Falls
Jul 30, 2024
06:48 AM EDT, 07/30/2024 (MT Newswires) -- Fresenius Medical Care ( FMS ) reported Q2 earnings Tuesday of 0.64 euros ($0.69) per share, up from 0.48 euros a year earlier. Analysts polled by Capital IQ expected 12.81 euros. Revenue for the quarter ended June 30 was 4.77 billion euros, down from 4.83 billion euros a year earlier. Analysts polled by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved